The 1st Immunogenicity – Determinants and Correlates Conference is a non-commercial meeting sponsored by the Institute for Immunology and Informatics (iCubed) at the University of Rhode Island. The conference is organized by individuals from a wide range of backgrounds including industry, academics and regulatory agencies such as the FDA, EMEA and NIHS (Japan).
The goal of this meeting is to provide an opportunity to discuss the drivers of immunogenicity and the application of scientific research to improving protein therapeutics and vaccines. The meeting will also bring together vaccine experts, immunologists and protein therapeutics developers for discussion of the latest determinants, correlates and models for predicting immunogenicity.
SAVE THE DATE – May 9, 10 and 11
1st Immunogenicity – Determinates and Correlates Conference, Providence, RI
Annie De Groot, University of Rhode Island
Terry Goletz, Amgen
Chris Bailey-Kellogg, Dartmouth
Leslie Cousens, EpiVax Inc.
Daniela Verthelyi, FDA
Eric Wakshull, Genentech
Sara Brett, GlaxoSmithKline
Bonita Rup, Pfizer
Michael Brehm, UMass
David Scott, Uniformed Services University of Health Sciences
Anish Suri, Bristol Myers Squibb
Nick Marsh, Adnexus
Andy Glasebrook, Eli Lilly
Dale Greiner, UMass
Amy Rosenberg, FDA
Naren Chirmule, Amgen
Michel Awwad, Pfizer
Denice Spero, University of Rhode Island
Alan Rothman, University of Massachusetts
Session I: Determinants – Predicting Immunogenicity
Session Chair and Panel Leaders:
Bonnie Rup, Pfizer and Terry Goletz, Amgen
Session II: Correlates – Biomarkers and Model Systems
Session Chair and Panel Leaders: Michel Brehm, UMass and David Scott, USUHS
Session III: Risk Mitigation – Preclinical Studies and Clinical Studies
Session Chair and Panel Leaders: Eric Furfine and Naren Chirmule, Amgen
Session IV: Case Studies
To be held in conjunction with the TRIAD Toolkit and Tregitope Meeting May 11th.
Please contact Karen Sorrento: firstname.lastname@example.org
Click here to register!
Click here for hotel accommodations!
Please contact Patrick Lowney with any questions: email@example.com
Abstracts due March 15
Please submit abstracts as a word document to Patrick Lowney: firstname.lastname@example.org
Authors of selected abstracts will be notified by April 1.